| Sumario: | It is our great pleasure to welcome you to the ACM workshop on Future of Digital Biomarkers 2021 (DigiBiom'21). The Workshop on the Future of Digital Biomarkers will offer a unified forum that brings academics, industry researchers and medical practitioners together to explore the role of existing and future mobile technology for modeling, testing, and validating new digital biomarkers. The workshop aims to facilitate a systematic discussion among experts from different knowledge domains including mobile sensing, systems, machine learning, medicine, and health sciences. The workshop aims to (i) identify new digital biomarkers for capturing different physiological and behavioral health conditions and diseases, (ii) identify the key shortcomings of the existing research in terms of scalability, customizability, and sensing affordances, (iii) find realistic solutions by leveraging sensor data from a variety of mobile systems (e.g., smartphones, wearables, and IoT devices), (iv) identify key methodologies for validation and testing of the new biomarker evidence engine. The call for papers attracted highly relevant submissions from around the world. The program committee accepted 5 full papers and 3 short papers out of 10 submissions. In addition to the presentations of the 8 accepted papers, the workshop will feature three keynote speakers and an industry panel. 1. Morning Keynote: "Social Media Derived Biomarkers of Mental Health: Opportunities, Pitfalls, and the Next Frontier", Prof. Munmun De Choudhury, School of Interactive Computing, Georgia Institute of Technology. 2. Afternoon Keynote: "Digital Epidemiology and the COVID-19 Pandemic", Prof. John Brownstein, Harvard Medical School. 3. Industry Panel: "Digital Biomarkers in the Health Technology Startup World" 4. Evening Keynote: "The Role of Science Policy in Developing Digital Biomarkers", Dr. Wendy Nilsen, National Science Foundation.
|
|---|
